CPhI NA 2024

Giving the gift of health by finding solutions to the cost and complexity of prescription drugs

By Liza Laws

- Last updated on GMT

© Gifthealth John Romano
© Gifthealth John Romano

Related tags CPhI North America Pharmacology Pharmaceutical industry Pharmaceutical drug Medicine Us

Gifthealth began operations just under four years ago to provide a scalable solution for the cost and complexity of prescription drugs.

The company was founded by healthcare technology startup veteran John Romano, and the company launched a pilot program in Ohio and quickly expanded into all 50 states.

Today, the team has grown to include technologists, data scientists, patient advocates, and path-to-purchase experts and the company’s purpose is simple: to help people get the prescribed care they need when they need it at the best possible price. Ahead of the company’s attendance at CPhI North America, we put some questions to to John Romano, its co-Founder and president.

What new products or innovations is your company showcasing at CPhI North America this year?

Gifthealth is releasing a best-in-class solution for drug manufacturers to ensure that the right drugs get the right patients and the right time. Our therapeutic areas of focus include GI, CNS, Respiratory, and Derm.            

How does your company stay ahead of industry trends and developments in the pharmaceutical sector?

We have high levels of HCP engagement within our areas of focus, in some areas, we have 15%+ of the total HCP universe on the platform and fulfilling through Gifthealth. We also offer market access and last-mile services to any manufacturer and can do it in a hublight setting.

Can you tell us about any recent partnerships or collaborations your company has formed to enhance its offerings?​  

Gifthealth has been incorporating AI and automation into many of our processes. These tools enable our team to work more efficiently and provide a high level of service to patients, providers, and manufacturers.

What challenges is your company currently facing in the pharmaceutical market, and how are you addressing them?​ 

Gifthealth collaborates closely with our partners to address all aspects of medication access and adherence. Reimbursements on branded medications present challenges for all pharmacies. Our team utilizes data to educate our manufacturing partners about the financial challenges a brand may pose to pharmacy economics. By collaborating closely, we can identify solutions that increase access points for patients to obtain their medication.

Can you provide insights into any regulatory changes or compliance issues that are impacting your business?​ 

Our team maintains a close relationship with various pharmacy boards, collaborating closely with them to stay abreast of regulatory changes. Gifthealth also partners with several compliance companies to ensure we remain informed and compliant.

What strategies does your company employ to ensure the quality and safety of its pharmaceutical products?​ 

Gifthealth does not manufacture medications, but we have a team of pharmacists dedicated to ensuring that patients receive appropriate medications and are well-informed throughout their therapy.

How does your company approach research and development to drive innovation and meet evolving customer needs?

Gift is a tech-forward company with a full engineering and data science team. In addition to our hub services, we provide data-driven dash boards to show a real ROI and script lift to our pharma customers.

What sets your company apart from competitors in the pharmaceutical industry, and what value do you offer to your customers?

We have best-in-class HCP coverage and engagement within our therapeutic areas of focus. Our ops team and proprietary platform is second to none and allow us to offer a seamless hub services solution that is quick and easy to implement, and competitive relative to any other hub on the market. Gifthealth offers a technology forward approach which allows us to offer solutions for specialty medications down to specialty lite and retail. 

Related news

Show more

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Pulmonary Delivery of Orally Inhaled Therapeutics

Pulmonary Delivery of Orally Inhaled Therapeutics

Content provided by Catalent Pharma Solutions | 19-Oct-2023 | Business Advice

New classes and indications of orally inhaled therapeutics are rapidly expanding, with the development pipeline increasingly featuring both large and small...

Related suppliers

Follow us


View more